Griem, Katharina; Falter, Tanja; Hollerbach, Anne et al.
Association of Specific Antiphospholipid Antibodies to Platelet Count and ThrombocytopeniaTHROMBOSIS AND HAEMOSTASIS. 2025
Oh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun et al.
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trialHEPATOLOGY. Bd. 81. H. 3. 2025 S. 823-836
Kloeckner, Roman; Mueller, Lukas; Heim, Lorena et al.
Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosisJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Kaps, Leonard; Genc, Muhammed A.; Moehler, Markus et al.
Collagen turnover biomarkers to predict outcome of patients with biliary cancerBMC GASTROENTEROLOGY. Bd. 25. H. 1. 2025
Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid et al.
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306) (vol 150, pg 112, 2022)INTERNATIONAL JOURNAL OF CANCER. Bd. 156. H. 1. 2025 S. E1-E1
Hahad, Omar; Schmitt, Volker H.; Baumkoetter, Rieke et al.
Earplug use during sleep and its association with cardiovascular disease - Results from a large sample of the general populationIJC HEART & VASCULATURE. Bd. 57. 2025
Lim, Ho Yeong; Heo, Jeong; Peguero, Julio A. et al.
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCCHEPATOLOGY. Bd. 81. H. 1. 2025 S. 32-43
Daza, Jimmy; Bezerra, Lucas Soares; Santamaria, Laura et al.
Evaluation of four chatbots in autoimmune liver disease: A comparative analysisANNALS OF HEPATOLOGY. Bd. 30. H. 1. 2025
Gairing, Simon Johannes; Mildenberger, Philipp; Gile, Jennifer et al.
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabJHEP REPORTS. Bd. 7. H. 3. 2025
Scholz, Constantin; Gerber, Tiemo Sven; Hoppe-Lotichius, Maria et al.
Extracapsular tumor spread does not influence survival outcomes in resected N1-patients with intrahepatic cholangiocarcinoma-a retrospectively controlled cohort studyEJSO. Bd. 51. H. 9. 2025